These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 29872866)
1. The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling. Qian H; Chen L; Huang J; Wang X; Ma S; Cui F; Luo L; Ling L; Luo K; Zheng G J Mol Med (Berl); 2018 Aug; 96(8):753-764. PubMed ID: 29872866 [TBL] [Abstract][Full Text] [Related]
2. LncRNA MIR4435-2HG-mediated upregulation of TGF-β1 promotes migration and proliferation of nonsmall cell lung cancer cells. Yang M; He X; Huang X; Wang J; He Y; Wei L Environ Toxicol; 2020 May; 35(5):582-590. PubMed ID: 31875359 [TBL] [Abstract][Full Text] [Related]
3. LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling. Wang H; Wu M; Lu Y; He K; Cai X; Yu X; Lu J; Teng L Aging (Albany NY); 2019 Sep; 11(17):6657-6673. PubMed ID: 31484163 [TBL] [Abstract][Full Text] [Related]
4. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder. Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516 [TBL] [Abstract][Full Text] [Related]
5. MIR4435-2HG: A novel biomarker for triple-negative breast cancer diagnosis and prognosis, activating cancer-associated fibroblasts and driving tumor invasion through EMT associated with JNK/c-Jun and p38 MAPK signaling pathway activation. Gu P; Ding W; Zhu W; Shen L; Zhang L; Wang W; Wang R; Wang W; Wang Y; Yan B; Sun X Int Immunopharmacol; 2024 Dec; 142(Pt B):113191. PubMed ID: 39317050 [TBL] [Abstract][Full Text] [Related]
7. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis. Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715 [TBL] [Abstract][Full Text] [Related]
8. LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis. Shen MY; Zhou GR; -Y Zhang Z Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1771-1777. PubMed ID: 32141545 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of long non-coding RNA MR4435-2HG suppresses breast cancer progression via the Wnt/β-catenin signaling pathway. Chen D; Tang P; Wang Y; Wan F; Long J; Zhou J; Zhuang M; Chen X Oncol Lett; 2021 May; 21(5):373. PubMed ID: 33777197 [TBL] [Abstract][Full Text] [Related]
10. The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a. Kong Q; Liang C; Jin Y; Pan Y; Tong D; Kong Q; Zhou J Cell Mol Biol Lett; 2019; 24():26. PubMed ID: 30988676 [TBL] [Abstract][Full Text] [Related]
11. Long-chain Non-coding RNA MIR4435-2HG Expression Correlates With Size of Intestinal Polyps in Children and With Metastasis of Colon Cancer. Zhu D; Guo P; Jin XY; Zhang R; Ji G; Yang Z; Hoffman RM; Sheng W Anticancer Res; 2022 Oct; 42(10):4707-4714. PubMed ID: 36191994 [TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway. Zhang S; Li C; Liu J; Geng F; Shi X; Li Q; Lu Z; Pan Y FEBS J; 2020 Sep; 287(18):4032-4047. PubMed ID: 31997506 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MIR4435-2HG recruits miR-802 from FLOT2 to promote melanoma progression. Ma DM; Sun D; Wang J; Jin DH; Li Y; Han YE Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2616-2624. PubMed ID: 32196611 [TBL] [Abstract][Full Text] [Related]
14. Long Non-coding RNA MIR4435-2HG Promotes Colorectal Cancer Proliferation and Metastasis Through miR-206/YAP1 Axis. Dong X; Yang Z; Yang H; Li D; Qiu X Front Oncol; 2020; 10():160. PubMed ID: 32154166 [No Abstract] [Full Text] [Related]
15. Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils. Yu H; Chen C; Han F; Tang J; Deng M; Niu Y; Lai M; Zhang H Cancer Immunol Res; 2022 Sep; 10(9):1095-1110. PubMed ID: 35862232 [TBL] [Abstract][Full Text] [Related]
16. MIR4435-2HG: A newly proposed lncRNA in human cancer. Zhang M; Yu X; Zhang Q; Sun Z; He Y; Guo W Biomed Pharmacother; 2022 Jun; 150():112971. PubMed ID: 35447550 [TBL] [Abstract][Full Text] [Related]
17. LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer. Ke J; Wang Q; Zhang W; Ni S; Mei H Am J Transl Res; 2022; 14(8):5441-5454. PubMed ID: 36105009 [TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539 [TBL] [Abstract][Full Text] [Related]
19. MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis. Zhong C; Xie Z; Zeng LH; Yuan C; Duan S Front Immunol; 2022; 13():855078. PubMed ID: 35784328 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer. Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]